Wilson Disease Association

The 100th Registry Participant

By Wilson Disease|2023-03-27T18:03:00+00:00March 27, 2023|Uncategorized|

Ultragenyx’s Wilson Disease Gene Therapy Program Update

By Wilson Disease|2023-06-02T15:55:40+00:00January 17, 2023|Clinical Trials|

GATEWAY IS NOW ACTIVELY ENROLLING AT 3 US CLINICAL SITES!

By Wilson Disease|2022-09-23T16:50:05+00:00September 23, 2022|Clinical Trials, Patient Registry Study|

Shipping Trientine to India through MAP International

By Wilson Disease|2022-03-10T13:38:40+00:00March 10, 2022|News and Notices|

Registration and availability of Trientine hydrochloride – Australia

By Wilson Disease|2021-04-22T12:36:59+00:00April 21, 2021|News and Notices|

Registration and availability of Trientine hydrochloride – Canada

By Wilson Disease|2021-04-22T12:34:43+00:00April 19, 2021|News and Notices|

Notice of Medication Discontinuation

By Wilson Disease|2021-03-26T12:59:13+00:00March 15, 2021|News and Notices|

Market Research Survey

By Wilson Disease|2021-03-26T12:59:19+00:00February 20, 2020|News and Notices|